8-K filing — Maplebear Inc. (CART)
Filed: 2026-10-29 AccNo: 0001193125-26-437075 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Filed: 2026-10-29 AccNo: 0001193125-26-437075 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068048 Size: 843 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0000102212-26-000041 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001493152-26-049188 Size: 302 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0000040211-26-000091 Size: 858 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068047 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068046 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0000105634-26-000132 Size: 518 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001140361-26-041111 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001688757-26-000056 Size: 550 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001193125-26-437071 Size: 248 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0000062234-26-000046 Size: 677 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068043 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001193125-26-437067 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0000820027-26-000050 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068030 Size: 879 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068028 Size: 358 KB Item 2.02: Results of Operations and Financial Condition
Filed: 2026-10-29 AccNo: 0000076605-26-000106 Size: 494 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001178670-26-000074 Size: 513 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001213900-26-113564 Size: 306 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001628280-26-068022 Size: 480 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Filed: 2026-10-29 AccNo: 0001213900-26-113562 Size: 220 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Geopolitical tensions involving Russia-Ukraine, Israel-Hamas, and Middle East conflicts are prompting investors to reassess portfolios with increased focus on energy mutual funds. Three top-ranked energy mutual funds with Zacks Rank #1 (Strong Buy) ratings are highlighted: Invesco Steelpath MLP Select 40 Fund (21.6% three-year returns), Vanguard Specialized Portfolios Energy Fund (18.5% three-year returns), and Invesco Energy Fund (15.7% three-year returns), offering diversified exposure to the energy sector.
Beam Therapeutics (BEAM) shares surged 15.6% following positive early-stage data for its experimental gene-editing treatment BEAM-301 for glycogen storage disease type Ia. The treatment showed improvements in fasting tolerance and glucose control in six patients, with two patients no longer requiring daily starch supplements. Despite some serious adverse events, the company plans to test higher doses and pursue FDA approval discussions. However, earnings estimate revisions remain unchanged, which may limit sustained momentum.
Zacks highlights two stocks with Rank #1 (Strong Buy) ratings and strong value characteristics: Murphy Oil Corporation (MUR), an oil and gas exploration company with a P/E of 11.82 and 37.2% earnings estimate increase over 60 days, and Albany International Corp. (AIN), a manufacturer of engineered materials with a P/E of 18.66 and 17.5% earnings estimate increase over 60 days.
Anthropic filed for its IPO on October 26, 2026, with a potential valuation exceeding SpaceX's record $85.7 billion raise. However, the article warns retail investors to avoid the IPO due to an extremely aggressive insider lockup schedule featuring 23 separate unlock events, including share sales on the first trading day after debut. Additionally, historical data shows that 57% of major tech IPOs since 2012 declined within 12 months, with an average maximum drawdown of 55%.
Gilat Satellite Networks announced that CEO Adi Sfadia and CFO Gil Benyamini will participate in the Deutsche Bank Global Space and Defense Tech Summit on November 18th, 2026 in New York, engaging in one-on-one and group meetings with investors and industry participants.
IonQ stock fell over 30% in October amid concerns about shareholder dilution and a broader tech sell-off. While the quantum computing company showed impressive 287% revenue growth in Q2 and has $3 billion in cash, it remains unprofitable with a $120.3 million EBITDA loss. The analyst recommends waiting on the sidelines until the company demonstrates a path to profitability, despite its appealing growth trajectory for risk-tolerant investors.
While QQQ has delivered exceptional 10-year returns of 20.5% by tracking tech-heavy Nasdaq-100 stocks, the author argues VTI (Vanguard Total Stock Market ETF) is a better long-term investment. Vanguard research suggests AI's ultimate winners may be smaller companies and value stocks that benefit from AI productivity gains rather than today's tech giants building AI infrastructure. VTI's broader diversification across 3,519 stocks positions it better to capture gains from overlooked sectors over the next 20-30 years.
Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, announced it will report third quarter 2026 financial results on November 5, 2026, followed by a virtual fireside chat with senior management on November 6, 2026. The company is developing oral recombinant vaccines for coronavirus, norovirus, influenza, and HPV using its proprietary pill-based delivery platform.